Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Enovis Corporation, 3 years.
Enovis Corporation
Director
BioMarin Pharmaceutical Inc.
Director
Option Care Health Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BioMarin Pharmaceutical Inc. June 2, 202699.5%
-
Option Care Health Inc. May 20, 202698.7%
-
Enovis Corporation May 21, 202599.9%
-
BioMarin Pharmaceutical Inc. May 20, 202599.4%
-
Option Care Health Inc. May 16, 202599.2%
-
BioMarin Pharmaceutical Inc. May 21, 202499.6%
-
Enovis Corporation May 20, 202498.6%
-
Option Care Health Inc. May 15, 202498.7%
-
Enovis Corporation May 16, 202399.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 2, 2026 | BioMarin Pharmaceutical Inc. | Grant or award | +7,490 | — | — |
| May 20, 2026 | Option Care Health Inc. | Grant or award | +8,997 | — | — |
| May 19, 2026 | Enovis Corporation | Grant or award | +9,346 | — | — |
| May 21, 2025 | Enovis Corporation | Grant or award | +6,598 | — | — |
| May 20, 2025 | BioMarin Pharmaceutical Inc. | Grant or award | +6,650 | — | — |
| May 14, 2025 | Option Care Health Inc. | Grant or award | +5,034 | — | — |
| May 21, 2024 | BioMarin Pharmaceutical Inc. | Grant or award | +4,720 | — | — |
| May 20, 2024 | Enovis Corporation | Grant or award | +4,338 | — | — |
| May 15, 2024 | Option Care Health Inc. | Grant or award | +5,325 | — | — |
| Apr 1, 2024 | Option Care Health Inc. | Grant or award | +1,731 | — | — |
| Dec 27, 2023 | BioMarin Pharmaceutical Inc. | Grant or award | +2,180 | — | — |
| May 16, 2023 | Enovis Corporation | Grant or award | +1,875 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.